Berlin, 10 January 2022. Eckert & Ziegler Radiopharma GmbH (EZR), the radiopharmaceutical production arm of Eckert & Ziegler, has signed a joint venture and exclusive long-term supply agreements for Ytterbium-176 with Atom Mines LLC, an innovative…
Berlin, Germany and New York, USA, January 6, 2022:
ProBioGen AG is delighted to announce the execution of a service and commercial product license agreement with Imvaq Therapeutics, a biotech company developing innovative cancer immunotherapies.…
BBI Solutions, the world’s leading independent provider of immuno-diagnostic reagents and contract services, has today announced the acquisition of “Biotez”.
BioTeZ Berlin-Buch GmbH (also including Steffens Biotechnische Analysen GmbH), is a…
Lindera – one of the leading deep-tech companies in the field of computer vision – has successfully closed a Series A financing round. The Berlin-based health-tech company is receiving additional growth capital from new investors as well as from…
TOKYO and Hennigsdorf, Germany, November 15, 2021 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Pantherna Therapeutics GmbH (CEO: Klaus Giese, Ph.D., “Pantherna”) today announced that the companies have…
Berlin, 5 November 2021. Eckert & Ziegler AG (ISIN DE0005659700), a global specialist for isotope applications in medicine and industry has acquired an approximately 7,000 m² property with an expansion option for the building of its Chinese…
When cells make the wrong decision, diseases ensue. This insight came from Berlin – namely from Rudolf Virchow, whose 200th birthday is being celebrated this year. To mark the anniversary, Berlin research institutions have announced the founding of…
You have an idea that needs to become reality? Your research could make this world a better place if turned into a product or service? Science & Startups and our network partners TU, HU, FU and Charité will help you along your journey!
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX) has received from the Berlin City Government a 66-year long-term lease for an industrial property with 53,000 square feet (5,000 square meters) of factory floor located at…
Berlin, August 13, 2021 -With the foundation of ASC Oncology Schweiz AG, cancer patients with malignant solid tumors and their treating oncologists can now also use a new test procedure in Switzerland. With the help of the Reverse Clinical…
